Lombard Odier Asset Management Switzerland SA Raises Position in The Clorox Company $CLX

Lombard Odier Asset Management Switzerland SA increased its position in shares of The Clorox Company (NYSE:CLXFree Report) by 7.5% in the 1st quarter, HoldingsChannel reports. The firm owned 108,600 shares of the company’s stock after purchasing an additional 7,600 shares during the period. Lombard Odier Asset Management Switzerland SA’s holdings in Clorox were worth $11,254,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Wilkins Investment Counsel Inc. boosted its stake in shares of Clorox by 250.6% in the fourth quarter. Wilkins Investment Counsel Inc. now owns 55,064 shares of the company’s stock valued at $5,552,000 after buying an additional 39,360 shares in the last quarter. Morningstar Investment Management LLC grew its holdings in Clorox by 131.8% during the fourth quarter. Morningstar Investment Management LLC now owns 62,454 shares of the company’s stock worth $6,297,000 after acquiring an additional 35,506 shares during the period. National Pension Service raised its position in Clorox by 68.9% in the fourth quarter. National Pension Service now owns 27,537 shares of the company’s stock worth $2,777,000 after acquiring an additional 11,233 shares in the last quarter. Birch Hill Investment Advisors LLC acquired a new stake in Clorox in the fourth quarter valued at $22,103,000. Finally, Ilmarinen Mutual Pension Insurance Co acquired a new stake in Clorox in the fourth quarter valued at $1,966,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Analyst Ratings Changes

CLX has been the topic of several research analyst reports. Evercore restated an “underperform” rating and set a $98.00 target price on shares of Clorox in a research report on Thursday. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and issued a $94.00 price target on shares of Clorox in a report on Wednesday. BNP Paribas Exane reduced their price objective on shares of Clorox from $97.00 to $95.00 and set a “neutral” rating for the company in a research note on Monday, July 20th. Zacks Research downgraded shares of Clorox from a “hold” rating to a “strong sell” rating in a report on Tuesday, May 12th. Finally, Barclays upped their target price on shares of Clorox from $85.00 to $86.00 and gave the stock an “underweight” rating in a research report on Tuesday, July 21st. One equities research analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have assigned a Sell rating to the company. According to MarketBeat.com, the stock has an average rating of “Reduce” and a consensus price target of $102.80.

Read Our Latest Analysis on Clorox

Insider Buying and Selling

In other Clorox news, Director Pierre R. Breber bought 5,000 shares of the company’s stock in a transaction on Tuesday, May 5th. The stock was purchased at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the acquisition, the director owned 18,000 shares of the company’s stock, valued at $1,544,760. The trade was a 38.46% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders own 0.63% of the company’s stock.

Clorox Stock Up 1.9%

Clorox stock opened at $95.61 on Friday. The company has a debt-to-equity ratio of 27.03, a quick ratio of 0.65 and a current ratio of 0.84. The firm has a market capitalization of $11.56 billion, a price-to-earnings ratio of 15.52 and a beta of 0.54. The Clorox Company has a fifty-two week low of $84.70 and a fifty-two week high of $131.86. The stock’s fifty day moving average is $95.10 and its two-hundred day moving average is $103.83.

Clorox (NYSE:CLXGet Free Report) last announced its quarterly earnings results on Thursday, April 30th. The company reported $1.64 earnings per share for the quarter, beating analysts’ consensus estimates of $1.55 by $0.09. The business had revenue of $1.67 billion during the quarter, compared to analysts’ expectations of $1.67 billion. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The business’s revenue for the quarter was up .1% on a year-over-year basis. During the same quarter last year, the business posted $1.45 earnings per share. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Analysts predict that The Clorox Company will post 5.52 EPS for the current fiscal year.

Clorox Company Profile

(Free Report)

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

Further Reading

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.